Company: TDBCP
Filing Date: 2025-02-26
Form Type: 424B3
Source: 0001140361-25-006068
Chunk: 0

Company: TORONTO DOMINION BANK
Filing Date: 2025-02-26
Form: 424B3
Chunk 0
---
Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-283969 Product Supplement MLN-WF-1 to the Prospectus dated February 26, 2025

| The Toronto-Dominion Bank        
 Senior Debt Securities, Series H 
 Principal at Risk Securities     |

Linked to One or More Indices, Exchange-Traded Funds or Equity Securities GENERAL TERMS The Toronto-Dominion Bank (the “ Bank”) may, from time to time, offer and sell securities linked to one or more equity indices (each, an “Index” and collectively, the “ Indices”), exchange-traded funds (each, a “ Fund” and collectively, the “ Funds”) or common equity securities or American depositary shares (“ ADSs”) of a company not affiliated with us (each, an “ Underlying Stock” and collectively, the “ Underlying Stocks”), or any combination thereof. The Indices, Funds and Underlying Stocks are sometimes referred to herein collectively as the “ Market Measures” and individually as a “ Market Measure.” Market-linked securities, such as the securities described in this product supplement, are principal-at-risk securities, which means that you may receive less than the original public offering price of the securities (the “ original offering price”) at maturity, depending on the performance of one or more Market Measures. We refer to all securities offered under this product supplement as the “ securities.” The securities are senior debt securities of The Toronto-Dominion Bank as referenced in the accompanying prospectus. Any payments due on the securities, including any repayment of principal, will be subject to credit risk of the Bank. If the Bank were to default on its obligations, you could lose some or all of your investment. This prospectus supplement, which we refer to as a “ product supplement,” describes some of the general terms that may apply to the securities. This product supplement supplements the disclosure in any pricing supplement that may reference it, the accompanying prospectus and/or any other accompanying supplement(s), as applicable. A separate pricing supplement will describe terms that apply to specific issuances of the securities and may include changes to the terms specified in this product supplement. If the disclosure in the relevant pricing supplement is inconsistent with the disclosure in this product supplement, any other accompanying prospectus supplement(s) or the accompanying prospectus (together, the “ base offering documents”), the disclosure in the relevant pricing supplement will control. You should carefully review the specific terms of the securities described in the applicable pricing supplement together with the information contained in this product supplement and the other